INTEGRATED BIOPHARMA INC Finance Lease, Liability, Undiscounted Excess Amount
INTEGRATED BIOPHARMA INC (INBP) had Finance Lease, Liability, Undiscounted Excess Amount of $12.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2026-05-08
- 2026-03-31: Finance Lease, Liability, Undiscounted Excess Amount $12.00K.
- 2025-12-31: Finance Lease, Liability, Undiscounted Excess Amount $14.00K.
- 2025-09-30: Finance Lease, Liability, Undiscounted Excess Amount $17.00K.
- 2025-06-30: Finance Lease, Liability, Undiscounted Excess Amount $19.00K.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-03-31 | $12.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $14.00K 10-Q · filed 2026-02-11 |
| 2025-09-30 | $17.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $19.00K 10-K · filed 2025-09-23 |
| 2025-03-31 | $6.00K 10-Q · filed 2025-05-14 |
| 2024-06-30 | $0.00 10-K · filed 2024-09-20 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 |
| 2023-12-31 | $0.00 10-Q · filed 2024-02-12 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-K · filed 2023-09-15 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 |
| 2022-12-31 | $0.00 10-Q · filed 2023-02-10 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 |
| 2022-06-30 | $0.00 10-K · filed 2022-09-13 |
| 2022-03-31 | $153.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $174.00K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $195.00K 10-Q · filed 2021-11-10 |
| 2021-03-31 | $235.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $259.00K 10-Q · filed 2021-02-12 |
| 2020-09-30 | $1.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.00K 10-K · filed 2020-09-23 |
| 2020-03-31 | $3.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $6.00K 10-Q · filed 2020-02-12 |
| 2019-09-30 | $25.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $14.00K 10-K · filed 2019-08-29 |
| 2019-03-31 | $20.00K 10-Q · filed 2019-05-15 |